Search - tctmd.com

Displaying 561 - 580 of 1006

Sort: Relevancy | Date

Presentation TCT 2016

Catheter-Directed Thrombolysis and Pharmacomechanical Lysis for Acute DVT: Patient Selection and Outcomes

Presenter: Michael D. Dake, Michael R. Jaff, Mahmood K. Razavi

October 31, 2016

Presentation TCT 2016

State of the Art Lecture: Latest Medical Therapies for DVT and PE - What the Interventionist Must Know!

Presenter: Michael D. Dake, Michael R. Jaff

October 31, 2016

Presentation TCT 2016

Valvular Heart Disease II: Mitral Regurgitation - Edge-to-Edge Repair for DMR and FMR

Presenter: Michael J. Lim, Molly Szerlip

October 31, 2016

News Conference News TCT 2016

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

Michael O'Riordan

October 31, 2016

Presentation TCT 2016

Debate: Bioabsorbable Polymer DES vs Durable Polymer DES -Biodegradable Polymer DES will Replace Durable Polymer DES!

Presenter: Stephan Windecker, Michael Joner

October 31, 2016

News Conference News TCT 2016

EXCEL 和 NOBLE：左主干 PCI/CABG 的选择结果相悖

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

EXCEL y NOBLE: Los Resultados Contrarios Plantean un Dilema a la Hora de Elegir entre PCI y CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo.

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Yael L. Maxwell

October 31, 2016

Presentation TCT 2016

Severe AS and LV Dysfunction

Presenter: Howard C. Herrmann, Vinod H. Thourani, G. Michael Deeb

October 31, 2016

Presentation TCT 2016

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Presenter: Donald Cutlip, Christian Hengstenberg, Michael Joner

October 31, 2016

Presentation TCT 2016

Rationale for and Design of TWILIGHT and GLOBAL LEADERS: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, C. Michael Gibson

October 30, 2016

Presentation TCT 2016

Management of Visceral Artery Aneurysms: When to Intervene and How to Do It

Presenter: Gary M. Ansel, Michael R. Jaff, Constantino S. Pena

October 30, 2016

Presentation TCT 2016

Future Therapy for Symptomatic HCM Patients With and Without Dynamic Obstruction

Presenter: George S. Hanzel, Antoine Lafont, Michael A. Fifer

October 30, 2016

Presentation TCT 2016

Great Debate 1: The Optimal Management of Chronic Mesenteric Ischemia Is Catheter-based Intervention!

Presenter: Gary M. Ansel, Michael R. Jaff, Herbert D. Aronow

October 30, 2016

Presentation TCT 2016

Debate: Surgery, Septal Ablation or Medical Therapy for Obstructive HCM Not so Fast: Try Optimizing Medical Therapy First!

Presenter: George S. Hanzel, Antoine Lafont, Michael A. Fifer

October 30, 2016

Presentation TCT 2016

Role of Papillary Muscle Relocation in Ischemic Mitral Valve Regurgitation

Presenter: Michael J. Mack, Francesco Maisano, Marco Moscarelli

October 30, 2016

Presentation TCT 2016

How Good Can Surgical Outcomes Be in Secondary MR?

Presenter: Michael J. Mack, Francesco Maisano, Michael Argenziano

October 30, 2016

Presentation TCT 2016

Applying Lessons From the CTSN to Clinical Practice

Presenter: Michael J. Mack, Francesco Maisano

October 30, 2016

Presentation TCT 2016

Minimally Invasive and Robotic Repair for Primary MR: Less Invasive With Great Outcomes?

Presenter: Michael J. Mack, Francesco Maisano, Robert L. Smith

October 30, 2016

Advertisement

Catheter-Directed Thrombolysis and Pharmacomechanical Lysis for Acute DVT: Patient Selection and Outcomes

State of the Art Lecture: Latest Medical Therapies for DVT and PE - What the Interventionist Must Know!

Valvular Heart Disease II: Mitral Regurgitation - Edge-to-Edge Repair for DMR and FMR

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

Debate: Bioabsorbable Polymer DES vs Durable Polymer DES -Biodegradable Polymer DES will Replace Durable Polymer DES!

EXCEL 和 NOBLE：左主干 PCI/CABG 的选择结果相悖

EXCEL y NOBLE: Los Resultados Contrarios Plantean un Dilema a la Hora de Elegir entre PCI y CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo.

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Severe AS and LV Dysfunction

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Rationale for and Design of TWILIGHT and GLOBAL LEADERS: What I Expect the Findings to Be But What Wont Surprise Me!

Management of Visceral Artery Aneurysms: When to Intervene and How to Do It

Future Therapy for Symptomatic HCM Patients With and Without Dynamic Obstruction

Great Debate 1: The Optimal Management of Chronic Mesenteric Ischemia Is Catheter-based Intervention!

Debate: Surgery, Septal Ablation or Medical Therapy for Obstructive HCM Not so Fast: Try Optimizing Medical Therapy First!

Role of Papillary Muscle Relocation in Ischemic Mitral Valve Regurgitation

How Good Can Surgical Outcomes Be in Secondary MR?

Applying Lessons From the CTSN to Clinical Practice

Minimally Invasive and Robotic Repair for Primary MR: Less Invasive With Great Outcomes?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content